The prognostic value of lymph node status among breast cancer subtypes.

  title={The prognostic value of lymph node status among breast cancer subtypes.},
  author={Guo-Shiou Liao and Y. Chou and Huan-Ming Hsu and Ming-Shen Dai and J. Yu},
  journal={American journal of surgery},
  volume={209 4},
  • Guo-Shiou Liao, Y. Chou, +2 authors J. Yu
  • Published 2015
  • Medicine
  • American journal of surgery
  • BACKGROUND Breast cancer subtypes (BCSs) are predictive of responses to specific therapies and of prognostic value for clinical outcomes. This study aimed to evaluate the relative 5-year overall survival (OS) and recurrence-free survival rates (RFS) based on lymph node (LN) status among BCSs. METHODS Medical records of 1,399 breast cancer patients treated from 2006 to 2011 were retrospectively reviewed. Pathologic findings, type of treatment, and OS and RFS were evaluated for 5 molecular… CONTINUE READING
    20 Citations
    Prognostic Value of Lymphangiogenesis Determinants in Luminal and Non-luminal Breast Carcinomas
    • 2
    • PDF
    Prognostic Value of Clinicopathological Factors for Indonesian Breast Carcinomas of Different Molecular Subtypes
    • 12
    • PDF


    Lymph node involvement in immunohistochemistry-based molecular classifications of breast cancer.
    • 34
    Outcome in breast molecular subtypes according to nodal status and surgical procedures.
    • 39
    • Highly Influential
    • PDF
    The Characteristics of Breast Cancer Subtypes: Implications for Treatment Guidelines and Individualized Treatment Strategies in China
    • 5
    Distribution, clinicopathologic features and survival of breast cancer subtypes in Southern China
    • 49
    Relative and disease-free survival for breast cancer in relation to subtype: a population-based study
    • 31
    Breast cancer subtypes and survival in Chinese women with operable primary breast cancer
    • 11
    Are Breast Cancer Subtypes Prognostic for Nodal Involvement and Associated with Clinicopathologic Features at Presentation in Early-Stage Breast Cancer?
    • 35